Die neuesten OTLK Reports werden am 2024-02-14 aktualisiert: 2023-Q42023-Q32022-Q4
Outlook Therapeutics logo
Outlook Therapeutics OTLK
€ 7.17 -3.37%

Outlook Therapeutics Kennzahlen 2011-2024 | OTLK

Kennzahlen Jährlich Outlook Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.8 -3.5 -2.9 -1.6 -0.6 -1.2 -0.8 -1.3 - - - - -

P/S

- - -3294.7 - 2.7 11.5 8.4 24.1 - - - - -

EPS

-0.2 -0.3 -0.3 -0.7 -2.0 -1.2 -1.7 -3.7 -5.4 - - - -

EV (Enterprise Value)

128 M 234 M 156 M 61 M 42 M 76.9 M 80.5 M 98.5 M 26.1 M 64.3 M - - -

EBITDA per Share

-0.21 -0.3 -0.34 -0.493 -1.19 -5.39 -11.1 -22.9 - - - - -

EV/EBITDA

-3.0 -1.4 -1.2 -1.9 -1.4 -1.6 - - - - -

PEG

0.04 0.08 0.05 -0.02 -0.01 -0.04 -0.02 0.14 - - - - -

P/B

-7.3 26.5 33.1 20.0 -2.0 -1.7 -1.0 -13.8 - - - - -

P/CF

-2.4 -4.1 -2.8 -1.8 -0.7 -1.0 -2.0 -1.5 - - - - -

ROE %

408.53 -756.04 -1153.86 -1246.85 320.56 144.60 126.44 1025.53 - - - - -

ROA %

-182.61 -231.54 -233.06 -178.59 -201.48 -135.04 -187.37 -224.96 - - - - -

ROCE %

367.97 -721.92 -1122.68 -944.73 793.26 303.78 448.29 -1583.27 - - - - -

Current Ratio

0.7 1.4 1.3 1.1 0.7 0.1 0.1 0.3 - - - - -

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Outlook Therapeutics

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.04 - -0.08 -0.03 -0.08 -0.25 -0.08 -0.09 -0.08 -0.27 -0.07 -0.09 -0.12 -0.69 -0.03 -0.36 -0.62 -1.74 -0.2 -0.62 -1 -9.96 -0.26 -0.33 -0.71 -1.37 -0.22 -0.34 -0.82 -3.43 -1.6 -0.32 -1.36 -3.67 -1.3 -1.61 - - - - - - - - - - - - - - - -

EBITDA per Share

-0.04 - - - -0.07 -0.22 -0.08 -0.09 -0.07 -0.26 -0.07 -0.08 -0.12 -0.47 -0.13 -0.29 -0.27 -1.43 -0.21 -0.25 -0.96 -4.22 -0.19 -0.37 -0.1 -1.3 -0.27 -0.11 -0.74 -2.58 -1.14 -1.22 -1.21 -3 -1.11 -1.47 - - - - - - - - - - - - - - - -

ROE %

733.90 193.84 -398.01 -861.07 -852.41 -763.60 -1034.68 -1043.01 -1051.68 -884.06 -916.93 -792.48 -591.01 -675.34 371.91 370.66 286.33 269.62 188.22 193.69 178.15 148.84 175.31 158.14 125.71 205.54 935.14 1348.66 1710.22 1678.50 908.14 499.69 76.67 76.67 20.92 - - - - - - - - - - - - - - - - -

ROA %

-156.90 -88.60 -269.86 -268.79 -285.59 -274.20 -267.24 -258.88 -287.22 -384.32 -338.33 -316.52 -332.32 -376.13 -390.39 -401.03 -424.66 -317.44 -255.17 -267.10 -213.92 -167.80 -244.14 -232.01 -197.56 -285.02 -296.59 -365.06 -436.36 -429.30 -347.44 -285.65 -118.74 -118.74 -32.39 - - - - - - - - - - - - - - - - -

ROCE %

636.55 164.92 -396.89 -811.34 -798.72 -726.10 -995.36 -1000.59 -1009.15 -846.74 -964.86 -761.45 -564.84 -673.85 421.70 343.29 234.27 246.73 167.82 161.09 174.79 148.54 179.07 172.61 141.90 210.74 912.98 1314.77 1649.50 1621.83 875.45 472.23 74.21 74.21 20.37 - - - - - - - - - - - - - - - - -

Current Ratio

0.5 0.7 0.9 1.2 1.3 1.4 2.1 2.1 2.6 1.2 1.6 1.2 0.5 1.2 1.2 1.2 0.3 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.8 0.4 0.4 0.4 0.5 0.8 0.8 0.8 - 0.6 0.6 - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.1 46.9 76.0 0.9 0.4 0.7 - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.1 46.9 76.0 0.9 0.4 0.7 - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.1 46.9 76.0 0.9 0.4 0.7 - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung